Summary: We identified CCL2 as a reliable serum biomarker in the canine model of Duchenne muscular dystrophy (DMD), establishing a baseline for using circulatory cytokines/chemokines as biomarkers in canine DMD studies. Here, CCL2 is linked to Duchenne muscular dystrophy.